English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94201/94201 (100%)
造訪人次 : 81599532      線上人數 : 3010
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/103447


    題名: Detection of alpha-methylacyl-CoA racemase (AMACR) A biomarker of prostate cancer, in patient blood samples using a nanoparticle electrochemical biosensor
    作者: 劉炯權;Lin, Po-Yuan;Cheng, Kai-Lun;McGuffin-Cawley, James D.;Shieu, Fuh-Sheng;Samia, Anna C.;Gupta, Sanjay;Cooney, Matthew;Thompson, Cheryl L.;Liu, Chung Chiun
    貢獻者: 工學院材料科學與工程研究所
    關鍵詞: alpha-methylacyl-CoA racemase (AMACR);biosensor;Biosensors;Blood;electrochemical;Electrochemistry;nanoparticles;Prostate cancer
    日期: 2012-01-01
    上傳時間: 2026-04-23 11:30:40 (UTC+8)
    出版者: MDPI Multidisciplinary Digital Publishing Institute;Switzerland: MDPI AG
    摘要: 摘要: Although still commonly used in clinical practice to screen and diagnose prostate cancer, there are numerous weaknesses of prostate-specific antigen (PSA) testing, including lack of specificity and the inability to distinguish between aggressive and indolent cancers. A promising prostate cancer biomarker, alpha-methylacyl-CoA racemase (AMACR), has been previously demonstrated to distinguish cancer from healthy and benign prostate cells with high sensitivity and specificity. However, no accurate clinically useful assay has been developed. This study reports the development of a single use, disposable biosensor for AMACR detection. Human blood samples were used to verify its validity, reproducibility and reliability. Plasma samples from 9 healthy males, 10 patients with high grade prostatic intraepithelial neoplasia (HGPIN), and 5 prostate cancer patients were measured for AMACR levels. The average AMACR levels in the prostate cancer patients was 10 fold higher (mean(SD) = 0.077 (0.10)) than either the controls (mean(SD) = 0.005 (0.001)) or HGPIN patients (mean(SD) = 0.004 (0.0005)). At a cutoff of between 0.08 and 0.9, we are able to achieve 100% accuracy in separating prostate cancer patients from controls. Our results provide strong evidence demonstrating that this biosensor can perform as a reliable assay for prostate cancer detection and diagnosis.
    其他題名: Biosensors (Basel)
    出版者: Switzerland: MDPI AG
    出版日期: 2012-09-26
    出處: Biosensors (Basel), 2012-09, Vol.2 (4), p.377-387
    資源來源: Publicly Available Content Database
    版權: Copyright MDPI AG 2012
    版權: 2012 by the authors; licensee MDPI, Basel, Switzerland. 2012
    識別號: ISSN: 2079-6374
    識別號: EISSN: 2079-6374
    識別號: DOI: 10.3390/bios2040377
    識別號: PMID: 25586028
    顯示於類別:[材料科學與工程研究所 ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML17檢視/開啟


    在NCUIR中所有的資料項目都受到原著作權保護.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明